Quantcast

Latest Statin Stories

2014-02-04 08:33:16

Urges Reinstatement of SPA for Heart Drug Vascepa NEW YORK, Feb. 4, 2014 /PRNewswire-USNewswire/ -- The EPA Drug Initiative (EPADI) asserts that the FDA did not live up to its own scientific integrity standards in rescinding the Special Protocol Assessment (SPA) related to the "ANCHOR" sNDA for the triglyceride (TG) lowering drug, Vascepa, and urges that the Agency adhere to its own policies in the appeal of the SPA rescission decision. (Photo:...

2014-02-02 23:01:23

The attorneys at Bernstein Liebhard LLP are investigating claims by potential Lipitor lawsuit claimants who may have developed Type 2 diabetes after taking the cholesterol-lowering statin. New York, NY (PRWEB) February 02, 2014 Plaintiffs in Lipitor lawsuits (http://www.thelipitorlawsuit.com/) continue to wait for a federal Panel’s decision on whether to consolidate cases over the cholesterol drug after inclement weather caused last week’s hearing on the matter to be postponed,...

2014-01-30 16:26:43

RUTHERFORD-2 Study Meets Co-Primary Endpoints of LDL Cholesterol Reduction THOUSAND OAKS, Calif., Jan. 30, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Phase 3 RUTHERFORD-2 (RedUction of LDL-C with PCSK9 InhibiTion in HEteRozygous Familial HyperchOlesteRolemia Disorder Study-2) trial evaluating evolocumab in combination with statins and other lipid-lowering therapies in patients with heterozygous familial hypercholesterolemia (HeFH) met its co-primary...

2014-01-28 23:03:12

The Firm is investigating Lipitor lawsuits on behalf of individuals who developed Type 2 diabetes, allegedly due to their use of the statin medication. New York, New York (PRWEB) January 28, 2014 For the second time in recent months, the U.S. Judicial Panel on Multidistrict Litigation (JPML) will consider establishing a federal multidistrict litigation for all federally-filed Lipitor lawsuits (http://www.thelipitorlawsuit.com/ ) involving allegations that the statin drug caused users to...

2014-01-27 14:44:16

A new analysis of animal studies on cholesterol-lowering statins by UC San Francisco researchers found that non-industry studies had results that favored the drugs even more than studies funded by industry. The analysis of 63 animal studies of statins, led by Lisa Bero, PhD, UCSF professor clinical pharmacy, was published online January 21, 2014, in the scientific journal PLoS Biology. In previous studies, Bero determined that drug-company-sponsored clinical trials were associated with...

2014-01-23 08:31:51

Study Meets Co-Primary Endpoints of LDL Cholesterol Reduction THOUSAND OAKS, Calif., Jan. 23, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Phase 3 GAUSS-2 (Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-2) trial evaluating evolocumab in patients with high cholesterol who cannot tolerate statins met its co-primary endpoints: the percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at week 12 and the...

2014-01-22 10:31:44

Icahn School of Medicine at Mount Sinai designs HDL nanoparticle to deliver statin medication inside inflamed blood vessels to prevent repeat heart attacks and stroke Up to 30 percent of heart attack patients suffer a new heart attack because cardiologists are unable to control inflammation inside heart arteries — the process that leads to clots rupturing and causing myocardial infarction or stroke. But a report in Nature Communications by Icahn School of Medicine at Mount Sinai...

2014-01-20 23:03:55

Icahn School of Medicine at Mount Sinai Designs HDL Nanoparticle to Deliver Statin Medication Inside Inflamed Blood Vessels to Prevent Repeat Heart Attacks and Stroke New York, NY (PRWEB) January 20, 2014 Up to 30 percent of heart attack patients suffer a new heart attack because cardiologists are unable to control inflammation inside heart arteries — the process that leads to clots rupturing and causing myocardial infarction or stroke. But a report in Nature Communications by Icahn...

2014-01-14 23:02:31

The Firm is investigating Lipitor lawsuits on behalf of patients who developed Type 2 diabetes, allegedly due to Lipitor. New York, NY (PRWEB) January 14, 2014 As dozens of Lipitor lawsuits (http://www.thelipitorlawsuit.com/ ) alleging use of the statin caused patients to develop Type 2 diabetes continue to move forward in courts around the country, Bernstein Liebhard LLP notes that Pfizer Inc. has also been named a defendant in a new whistleblower lawsuit involving the...

2014-01-14 11:00:16

Dense heart plaques may have protective quality A study led by researchers at the University of California, San Diego School of Medicine shows that one of the most widely used systems for predicting risk of adverse heart events should be re-evaluated. A surprise finding was that coronary artery calcium (CAC) density may be protective against cardiovascular events. The study of CAC will be published in the January 15 issue of the Journal of the American Medical Association (JAMA). Great...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related